<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M868</article-id>
      <article-id pub-id-type="publisher-id">molbank-2015-M868</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>1,1&#x2032;-{1,4-Phenylene bis[3-(6-chloro-2-methyl-4-phenylquinolin-3-yl)-4,5-dihydro-1<italic>H</italic>-pyrazole-5,1-diyl]}dibutan-1-one</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kedjadja</surname>
            <given-names>Allaoua</given-names>
          </name>
          <xref rid="af1-molbank-2015-M868" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2015-M868" ref-type="aff">2</xref>
          <xref rid="c1-molbank-2015-M868" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kolli</surname>
            <given-names>Elhadj</given-names>
          </name>
          <xref rid="af1-molbank-2015-M868" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bouraiou</surname>
            <given-names>Abdelmalek</given-names>
          </name>
          <xref rid="af3-molbank-2015-M868" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Merdes</surname>
            <given-names>Rachid</given-names>
          </name>
          <xref rid="af1-molbank-2015-M868" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haddour</surname>
            <given-names>Naoufel</given-names>
          </name>
          <xref rid="af4-molbank-2015-M868" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>Haider</surname>
            <given-names>Norbert</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2015-M868"><label>1</label>Laboratoire de chimie Appliqu&#xE9;e, Facult&#xE9; des Math&#xE9;matiques et de l&#x2019;Informatique et des Sciences de la Mati&#xE8;re, Universit&#xE9; de Guelma, Guelma 24000, Algeria; E-Mails: <email>kollielhadj@gmail.com</email> (E.K.); <email>merdesra@yahoo.fr</email> (R.M.)</aff>
      <aff id="af2-molbank-2015-M868"><label>2</label>D&#xE9;partement de Tronc Commun, Facult&#xE9; des Science de la Nature et de la Vie, Universit&#xE9; Abderrahmane Mira Bejaia, Bejaia 6000, Algeria</aff>
      <aff id="af3-molbank-2015-M868"><label>3</label>Unit&#xE9; de Recherche de Chimie de l&#x2019;Environnement et Mol&#xE9;culaire Structurale, Universit&#xE9; des Fr&#xE8;res Mentouri, Route de Ain El Bey, Constantine 25000, Algeria; E-Mail: <email>bouraiou.abdelmalek@yahoo.fr</email></aff>
      <aff id="af4-molbank-2015-M868"><label>4</label>Laboratoire Amp&#xE8;re, UMR CNRS 5005, Ecole Centrale de Lyon, Universit&#xE9; Claude Bernard Lyon 1, Ecully 69130, France; E-Mail: <email>naoufel.haddour@ec-lyon.fr</email></aff>
      <author-notes>
        <corresp id="c1-molbank-2015-M868"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>kedjadjaalla@yahoo.fr</email> or <email>allaoua.kedjadja@univ-bejaia.dz</email>; Tel.: +213-07-73012507; Fax: +213-031818816.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>05</day>
        <month>10</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <volume>2015</volume>
      <issue>4</issue>
      <elocation-id>M868</elocation-id>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>07</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>09</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>A new polycyclic compound, 1,1&#x2032;-{1,4-phenylene bis[3-(6-chloro-2-methyl-4-phenylquinolin-3-yl)-4,5-dihydro-1<italic>H</italic>-pyrazole-5,1-diyl]}dibutan-1-one (<bold>3</bold>) has been synthesized by cyclocondensation of (2<italic>E</italic>,2&#x2032;<italic>E</italic>)-1,1&#x2032;-bis(6-chloro-2-methyl-4-phenylquinolin-3-yl)-3,3&#x2032;-(1,4-phenylene)diprop-2-en-1-one (<bold>2</bold>) and hydrazine hydrate in butanoic acid. The structure of this compound was established by elemental analysis, <sup>1</sup>H-NMR, <sup>13</sup>C-NMR, mass and IR spectroscopy.</p>
      </abstract>
      <kwd-group>
        <kwd>quinoline</kwd>
        <kwd>pyrazoline</kwd>
        <kwd>cyclocondensation</kwd>
        <kwd>terephthalaldehyde</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-molbank-2015-M868" sec-type="intro">
      <title>1. Introduction</title>
      <p>Quinoline nucleus is an important pharmacophore found in a large number of natural products and synthetic compounds with a wide range of applications. Indeed quinoline derivatives are some of the oldest compounds which have been utilized for the treatment of a variety of diseases; the bark of Cinchona plants containing quinine has been utilized to treat palpitations [<xref ref-type="bibr" rid="B1-molbank-2015-M868">1</xref>]. Compounds containing quinoline motif are most widely used as antimalarials [<xref ref-type="bibr" rid="B2-molbank-2015-M868">2</xref>], antibacterials [<xref ref-type="bibr" rid="B3-molbank-2015-M868">3</xref>], antifungals [<xref ref-type="bibr" rid="B4-molbank-2015-M868">4</xref>] and anticancer agents [<xref ref-type="bibr" rid="B5-molbank-2015-M868">5</xref>]. On the other hand, the pyrazoline moiety is an important nitrogen-containing 5-membered heterocyclic compound and various synthetic methods for their preparation have been reported [<xref ref-type="bibr" rid="B6-molbank-2015-M868">6</xref>]. Numerous pyrazoline derivatives have been found to possess considerable biological activities, which has stimulated the research activity in this field. They have several prominent effects, such as antimicrobial [<xref ref-type="bibr" rid="B7-molbank-2015-M868">7</xref>], antimycobacterial [<xref ref-type="bibr" rid="B8-molbank-2015-M868">8</xref>], anti-inflammatory, analgesic [<xref ref-type="bibr" rid="B9-molbank-2015-M868">9</xref>] and antiamoebic activity [<xref ref-type="bibr" rid="B10-molbank-2015-M868">10</xref>]. 2-Pyrazolines seem to be the most frequently studied pyrazoline type compounds. As a result, a large number of 2-pyrazolines using different synthetic methods for their preparation have been described in the chemistry literature. An especially popular procedure is based on the reaction of <italic>&#x3B1;</italic>,<italic>&#x3B2;</italic>-unsaturated ketones with hydrazines [<xref ref-type="bibr" rid="B11-molbank-2015-M868">11</xref>,<xref ref-type="bibr" rid="B12-molbank-2015-M868">12</xref>,<xref ref-type="bibr" rid="B13-molbank-2015-M868">13</xref>]. The coupling of this chemical entity with a quinoline unit might be considered to have some biological activities. Here we are reporting a novel bis[3-(quinol-3-yl)pyrazoline] prepared by cyclocondensation of the known (2<italic>E</italic>,2&#x2032;<italic>E</italic>)-1,1&#x2032;-bis(6-chloro-2-methyl-4-phenylquinolin-3-yl)-3,3&#x2032;-(1,4-phenylene)diprop-2-en-1-one (<bold>2</bold>) in presence of hydrazine hydrate (<xref ref-type="scheme" rid="molbank-2015-M868-sch001">Scheme 1</xref>).</p>
    </sec>
    <sec id="sec2-molbank-2015-M868">
      <title>2. Experimental Section</title>
      <sec id="sec2dot1-molbank-2015-M868">
        <title>2.1. General Methods</title>
        <p>The starting materials were generally used as received (Acros, Fontenay-sous-Bois, France) without any further purification. Melting points were determined on an electrothermal capillary fine-control apparatus and are uncorrected. All IR spectra were performed on Shimadzu FT-IR-8201 PC spectrophotometer (Constantine, Algeria) and only significant absorption-band frequency is cited. <sup>1</sup>H-NMR and <sup>13</sup>C-NMR spectra were recorded in deuterated chloroform on a Br&#xFC;ker Avance DPX 250 spectrometer (Constantine, Algeria) at 250 MHz for proton and at 62.9 MHz for <sup>13</sup>C. Chemical shifts are given in ppm and <italic>J</italic> values in Hertz (Hz). The mass spectrum was scanned on a Shimadzu GCMS-QP2010 and the elemental analysis was obtained using a LECO CHNS-900 elemental analyzer (Lyon, France) and the values are within &#xB1;0.4% of the theoretical values.</p>
        <p>3-Acetyl-6-chloro-2-methyl-4-phenylquinoline (<bold>1</bold>) has been synthesized in accordance with established methods [<xref ref-type="bibr" rid="B14-molbank-2015-M868">14</xref>]. Spectroscopic results and physical properties are in agreement with literature reports [<xref ref-type="bibr" rid="B15-molbank-2015-M868">15</xref>,<xref ref-type="bibr" rid="B16-molbank-2015-M868">16</xref>].</p>
      </sec>
      <sec id="sec2dot2-molbank-2015-M868">
        <title>2.2. Synthesis of 1,1&#x2032;-{1,4-phenylene bis[3-(6-chloro-2-methyl-4-phenylquinolin-3-yl)-4,5-dihydro-1H-pyrazole-5,1-diyl]}dibutan-1-one <italic>(<bold>3</bold>)</italic></title>
        <p>A solution of 3-acetyl-6-chloro-2-methyl-4-phenylquinoline (2.00 g, 6.7682 mmol, 2 eq.) and terephthalaldehyde (0.4568 g, 3.3841 mmol, 1 eq.) in an ethanolic solution of NaOH 10% (1.0 g in 10 mL of ethanol) was stirred for 8 h at room temperature. The solution was poured into ice cold water and solution was adjusted to pH ~ 2 by HCl (1 N). The solid was separated off and then dissolved in CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed with a saturated solution of NaHCO<sub>3</sub> and the solvent was evaporated to dryness. The residue was recrystallized from ethyl acetate/petroleum ether (1/1) solution to give the intermediate compound (<bold>2</bold>), m.p.: &#x2C3;300 &#xB0;C, yield: 75%. Compound <bold>2</bold> is known in literature [<xref ref-type="bibr" rid="B17-molbank-2015-M868">17</xref>] and its structure has been confirmed by spectroscopic methods. Next, the title compound (<bold>3</bold>) was prepared by heating (2<italic>E</italic>,2&#x2032;<italic>E</italic>)-1,1&#x2032;-Bis(6-chloro-2-methyl-4-phenylquinolin-3-yl)-3,3&#x2032;-(1,4-phenylene)diprop-2-en-1-one <bold>2</bold> (1.0 g, 0.0014 mol) and hydrazine hydrate (0.1451 g, 0.0029 mol) in butanoic acid (20 mL) at 115&#x2013;120 &#xB0;C for 6 h. After completion, the solution was cooled, and then poured onto ice. The resulting solid was filtered, washed with water, dried, and then recrystallized from chloroform/ethyl acetate mixture (1:1).</p>
        <p>White powder; (50% EtOAc in CH<sub>3</sub>Cl, R<sub>f</sub> = 0.46); Yield: 86%; m.p. &#x2C3; 300 &#xB0;C.</p>
        <p>HRMS (ESI): [M + H]<sup>+</sup> calculated for C<sub>52</sub>H<sub>47</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub> = 857.3138; found 857.3126.</p>
        <p>IR (KBr) <italic>v</italic><sub>max</sub> cm<sup>&#x2212;1</sup>: 1639.4 (C=O ketone), 1566.1 (C=N pyrazoline).</p>
        <p><sup>1</sup>H-NMR (250 MHz, CDCl<sub>3</sub>) &#x3B4;: 8.66 (d, <italic>J</italic> = 8.4 Hz, 2H, H-8 quinoline), 8.28 (dd, <italic>J</italic> = 8.4 Hz, <italic>J</italic> = 1.7 Hz, 2H, H-7 quinoline), 8.07-7.91 (m, 10H, H-Ar), 7.87&#x2013;7.79 (m, 4H, H-Ar), 7.21 (s, 4H, phenylene), 5.86 (dd, <italic>J</italic> = 12.0 Hz, <italic>J</italic> = 5.0 Hz, 2H, H-5 pyrazoline), 3.64 (dd, <italic>J</italic> = 18.4 Hz, <italic>J</italic> = 12.0 Hz, 2H, H-4 pyrazoline), 3.36 (s, 6H, 2CH<sub>3</sub>), 3.33-3.16 (m, 4H, 2CH<sub>2</sub>), 2.98 (dd, <italic>J</italic> = 18.4 Hz, <italic>J</italic> = 5.0 Hz, 2H, H-4&#x2032; pyrazoline), 2.12&#x2013;2.35 (m, 4H, 2CH<sub>2</sub>), 1.52 (t, <italic>J</italic> = 7.5 Hz, 6H, 2CH<sub>3</sub>).</p>
        <p><sup>13</sup>C-NMR (62.9 MHz, CDCl<sub>3</sub>) &#x3B4;: 171.82 (2CO), 156.55 (2C, C2 quinoline), 154.07(2C, C3 pyrazoline), 148.43, 147.52, 140.72, 135.67, 130.48, 130.02, 129.60, 128.87, 128.76, 128.65, 126.64, 126.48, 126.04, 125.80, 124.68 (C, CH phenyl and quinoline, 34C), 59.28 (2CH, C5 pyrazoline), 46.30 (2CH<sub>2</sub>, C4 pyrazoline), 36.42 (2CH<sub>2</sub>), 24.87 (2CH<sub>2</sub>), 18.77 (2CH<sub>3</sub>), 14.10 (2CH<sub>3</sub>).</p>
        <p>Anal. calcd. For C<sub>52</sub>H<sub>46</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub>: C, 72.80; H, 5.40; N, 9.80; Found C, 72.82; H, 5.39; N, 9.83.</p>
        <p>Copies of these spectra should be provided in the <xref ref-type="app" rid="app1-molbank-2015-M868">Supplementary Materials</xref>.</p>
      </sec>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2015-M868">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2015-M868-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M868-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2015-M868-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M868-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
        <supplementary-material id="molbank-2015-M868-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M868-s002.pdf">
   <label>Supplementary File 3</label>
</supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank ANDRS (Agence Nationale pour le D&#xE9;veloppement de la Recherche en Sant&#xE9;) and MESRS (Minist&#xE8;re de 1&#x2019;Enseignement Sup&#xE9;rieur et de la Recherche Scientifique) for partial financial support.</p>
    </ack>
    <notes>
      <title>Author Contributions</title>
      <p>Kedjadja Allaoua and Merdes Rachid have contributed to the experimental part of this work. Experimental characterization was made by Kolli Elhadj. Bouraiou Abdelmalek and Haddour Naoufel analyzed the NMR and have contributed to the preparation of the manuscript. All authors read and approve the final manuscript.</p>
    </notes>
    <notes>
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2015-M868">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levy</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Azoulay</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Stories About the Origin of Quinquina and Quinidine</article-title>
          <source>J. Cardiovas. Electrophysiol.</source>
          <year>1994</year>
          <volume>5</volume>
          <fpage>635</fpage>
          <lpage>636</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1540-8167.1994.tb01304.x</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2015-M868">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roma</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Braccio</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Grossi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Mattioli</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ghia</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>1,8-Naphthyridines IV. 9-Substituted <italic>N</italic>,<italic>N</italic>-dialkyl-5-(alkylamino or cycloalkylamino) [1,2,4]triazolo[4,3-<italic>a</italic>][1,8]naphthyridine-6-carboxamides, new compounds with anti-aggressive and potent anti-inflammatory activities</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2000</year>
          <volume>35</volume>
          <fpage>1021</fpage>
          <lpage>1035</lpage>
          <pub-id pub-id-type="doi">10.1016/S0223-5234(00)01175-2</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2015-M868">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phan</surname>
              <given-names>L.T.</given-names>
            </name>
            <name>
              <surname>Jian</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Qiu</surname>
              <given-names>Y.L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Beach</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Polemeropoulos</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Or</surname>
              <given-names>Y.S.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and Antibacterial Activity of a Novel Class of 4&#x2032;-Substituted 16-Membered Ring Macrolides Derived from Tylosin</article-title>
          <source>J. Med. Chem.</source>
          <year>2004</year>
          <volume>47</volume>
          <fpage>2965</fpage>
          <lpage>2968</lpage>
          <pub-id pub-id-type="doi">10.1021/jm034233n</pub-id>
          <pub-id pub-id-type="pmid">15163176</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2015-M868">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vargas</surname>
              <given-names>L.Y.</given-names>
            </name>
            <name>
              <surname>Castelli</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Kouznetsov</surname>
              <given-names>V.V.</given-names>
            </name>
            <name>
              <surname>Urbina</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>S.N.</given-names>
            </name>
            <name>
              <surname>Sortino</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Enriz</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Ribas</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Zacchino</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title><italic>In vitro</italic> antifungal activity of new series of homoallylamines and related compounds with inhibitory properties of the synthesis of fungal cell wall polymers</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2003</year>
          <volume>11</volume>
          <fpage>1531</fpage>
          <lpage>1550</lpage>
          <pub-id pub-id-type="doi">10.1016/S0968-0896(02)00605-3</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2015-M868">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dassonneville</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lansiaux</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wattelet</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wattez</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Mahieu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Van Miert</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pieters</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bailly</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: Relation to drug-induced apoptosis</article-title>
          <source>Eur. J. Pharmacol.</source>
          <year>2000</year>
          <volume>409</volume>
          <fpage>9</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="doi">10.1016/S0014-2999(00)00805-0</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2015-M868">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levai</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of pyrazolines by the reactions of <italic>&#x3B1;</italic>,<italic>&#x3B2;</italic>-enones with diazomethane and hydrazines</article-title>
          <source>Chem. Heterocycl. Compd.</source>
          <year>1997</year>
          <volume>33</volume>
          <fpage>647</fpage>
          <lpage>659</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02291794</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2015-M868">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>&#xD6;zdemir</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zitouni</surname>
              <given-names>T.G.</given-names>
            </name>
            <name>
              <surname>Kaplanc&#x131;kl&#x131;</surname>
              <given-names>Z.A.</given-names>
            </name>
            <name>
              <surname>Revial</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>G&#xFC;ven</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antimicrobial activity of 1-(4-aryl-2-thiazolyl)-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2007</year>
          <volume>42</volume>
          <fpage>403</fpage>
          <lpage>409</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2006.10.001</pub-id>
          <pub-id pub-id-type="pmid">17125888</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2015-M868">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shaharyar</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Siddiqui</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Sriram</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Yogeeswari</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and <italic>in vitro</italic> antimycobacterial activity of <italic>N</italic><sup>1</sup>-nicotinoyl-3-(4&#x2032;-hydroxy-3&#x2032;-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>3947</fpage>
          <lpage>3949</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2006.05.024</pub-id>
          <pub-id pub-id-type="pmid">16725324</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2015-M868">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Manna</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Chimenti</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Bolasco</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Cenicola</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>D&#x2019;Amico</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Parrillo</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Marmo</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Anti-inflammatory, analgesic and antipyretic N-acetyl-&#x394;<sup>2</sup>-pyrazolines and dihydrothienocoumarines</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>1992</year>
          <volume>27</volume>
          <fpage>633</fpage>
          <lpage>639</lpage>
          <pub-id pub-id-type="doi">10.1016/0223-5234(92)90142-N</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2015-M868">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhat</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Athar</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Azam</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Bis-pyrazolines: Synthesis, characterization and antiamoebic activity as inhibitors of growth of <italic>Entamoeba histolytica</italic></article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2009</year>
          <volume>44</volume>
          <fpage>426</fpage>
          <lpage>431</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2007.11.005</pub-id>
          <pub-id pub-id-type="pmid">18187238</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2015-M868">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Manna</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Chimenti</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Bolasco</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Secci</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bizzarri</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Befani</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Turini</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Mondovi</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Alcaro</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tafi</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of amine oxidases activity by 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2002</year>
          <volume>12</volume>
          <fpage>3629</fpage>
          <lpage>3633</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-894X(02)00699-6</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2015-M868">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levai</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Patonay</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>A.M.S.</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>D.C.G.A.</given-names>
            </name>
            <name>
              <surname>Cavaleiro</surname>
              <given-names>J.A.S.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of 3-aryl-5-styryl-2-pyrazolines by the reaction of (<italic>E,E</italic>)-cinnamylideneacetophenones with hydrazines and their oxidation into pyrazoles</article-title>
          <source>J. Heterocycl. Chem.</source>
          <year>2002</year>
          <volume>39</volume>
          <fpage>751</fpage>
          <lpage>758</lpage>
          <pub-id pub-id-type="doi">10.1002/jhet.5570390421</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2015-M868">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kedjadja</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kolli</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Bouraiou</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Merdes</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>1-[3-(2-Methyl-4-phenylquinolin-3-yl)-5-phenyl-4,5-dihydro-1<italic>H-</italic>pyrazol-1-yl]-propane-1-one</article-title>
          <source>Molbank</source>
          <year>2015</year>
          <volume>2015</volume>
          <fpage>M863</fpage>
          <pub-id pub-id-type="doi">10.3390/M863</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2015-M868">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>G.W.</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>Y.W.</given-names>
            </name>
          </person-group>
          <article-title>Benign and highly efficient synthesis of quinolines from 2-aminoarylketone or 2-aminoarylaldehyde and carbonyl compounds mediated by hydrochloric acid in water</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2006</year>
          <volume>47</volume>
          <fpage>1059</fpage>
          <lpage>1063</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tetlet.2005.12.053</pub-id>
        </citation>
      </ref>
      <ref id="B15-molbank-2015-M868">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kotra</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Ganapaty</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Adapa</surname>
              <given-names>S.R.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of new series of quinolinylchalcones as anticancer and anti-inflammatory agents</article-title>
          <source>Indian J. Chem. Sec. B</source>
          <year>2010</year>
          <volume>49</volume>
          <fpage>1109</fpage>
          <lpage>1116</lpage>
        </citation>
      </ref>
      <ref id="B16-molbank-2015-M868">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fun</surname>
              <given-names>H.K.</given-names>
            </name>
            <name>
              <surname>Loh</surname>
              <given-names>W.S.</given-names>
            </name>
            <name>
              <surname>Sarveswari</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vijayakumar</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>B.P.</given-names>
            </name>
          </person-group>
          <article-title>1-(6-Chloro-2-methyl-4-phenyl-3-quinolyl)ethanone</article-title>
          <source>Acta Crystallogr.</source>
          <year>2009</year>
          <volume>E65</volume>
          <fpage>o2688</fpage>
          <lpage>o2689</lpage>
          <pub-id pub-id-type="doi">10.1107/S1600536809040306</pub-id>
          <pub-id pub-id-type="pmid">21578294</pub-id>
        </citation>
      </ref>
      <ref id="B17-molbank-2015-M868">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kedjadja</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Merdes</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Bouacida</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Roisnel</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Belfaitah</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>(2<italic>E</italic>,2&#x2032;<italic>E</italic>)-1,1&#x2032;-Bis(6-chloro-2-methyl-4-phenylquinolin-3-yl)-3,3&#x2032;-(1,4-phenylene)diprop-2-en-1-one ethyl acetate disolvate</article-title>
          <source>Acta Crystallogr.</source>
          <year>2013</year>
          <volume>E69</volume>
          <fpage>o37</fpage>
          <lpage>o38</lpage>
          <pub-id pub-id-type="doi">10.1107/S1600536812049422</pub-id>
          <pub-id pub-id-type="pmid">23476424</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2015-M868-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2015-M868-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>The synthesis of 1,1&#x2032;-{1,4-phenylene bis[3-(6-chloro-2-methyl-4-phenylquinolin-3-yl)-4,5-dihydro-1<italic>H</italic>-pyrazole-5,1-diyl]}dibutan-1-one.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2015-M868-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
